Machina Capital S.A.S. lifted its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 34.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,664 shares of the financial services provider’s stock after purchasing an additional 5,824 shares during the period. Machina Capital S.A.S.’s holdings in MetLife were worth $2,134,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the business. Nvwm LLC increased its position in MetLife by 655.3% during the third quarter. Nvwm LLC now owns 287 shares of the financial services provider’s stock worth $27,000 after buying an additional 249 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of MetLife in the second quarter worth about $26,000. Burk Holdings LLC acquired a new stake in shares of MetLife in the second quarter worth about $27,000. Highland Investment Advisors LLC bought a new stake in shares of MetLife during the 2nd quarter worth about $30,000. Finally, Elevation Wealth Partners LLC boosted its stake in shares of MetLife by 123.5% during the 3rd quarter. Elevation Wealth Partners LLC now owns 362 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 200 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, CEO Michel Khalaf sold 187,425 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the transaction, the chief executive officer directly owned 759,013 shares in the company, valued at $78,155,568.61. The trade was a 19.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.40% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of brokerages have recently commented on MET. Argus increased their price objective on MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a report on Wednesday, September 2nd. Weiss Ratings upgraded MetLife from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday. UBS Group upped their target price on MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, October 6th. TD Cowen increased their price target on MetLife from $110.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, October 21st. Finally, Morgan Stanley lifted their price target on shares of MetLife from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, August 24th. Fourteen analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $107.12.
View Our Latest Research Report on MET
MetLife Trading Down 1.0%
Shares of NYSE:MET opened at $101.87 on Friday. The company has a market cap of $64.02 billion, a P/E ratio of 13.28, a P/E/G ratio of 0.97 and a beta of 0.79. The stock’s 50-day moving average is $98.68 and its 200-day moving average is $86.77. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $106.72. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.20 and a current ratio of 0.21.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 EPS for the quarter, topping analysts’ consensus estimates of $2.77 by $0.01. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The business had revenue of $20.52 billion for the quarter, compared to analyst estimates of $19.86 billion. During the same period in the previous year, the company posted $2.34 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis. Equities research analysts predict that MetLife, Inc. will post 9.94 earnings per share for the current year.
MetLife announced that its Board of Directors has initiated a stock repurchase program on Wednesday, August 5th that authorizes the company to buy back $3 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be issued a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a yield of 2.3%. MetLife’s dividend payout ratio (DPR) is 30.90%.
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Read More
- Five stocks we like better than MetLife
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
